World Health Day is celebrated annually on April 7th to recognise the World Health Organisation’s (WHO) founding in 1948. The day aims to raise awareness about global health issues and efforts to address them. In 2019, 262 million people worldwide had asthma, with 9.1% of those being children (aged 6-7)1,... read more →

NObreath® FeNO device and Gastrolyzer® range of devices are now available across the Middle East. Bedfont® Scientific Limited, a world leader in breath analysis with over 47 years of knowledge and expertise in designing and manufacturing medical breath analysis devices, has partnered with Tebaba Medical Services, a leading supplier of... read more →

On Wednesday, 27th November, the National Institute for Health and Care Excellence (NICE), the British Thoracic Society (BTS), and the Scottish Intercollegiate Guidelines Network (SIGN) updated and published a joint guideline on asthma diagnosis, monitoring, and chronic asthma management. Streamlining asthma management BTS/SIGN and NICE published guidelines independent of each... read more →

Bedfont® outlines key updates and offers support for healthcare professionals navigating the changes. Bedfont® Scientific Ltd., world leaders in breath analysis with over 47 years of knowledge in designing and manufacturing medical breath analysis devices, welcomes the recent update to the National Institute for Health and Care Excellence (NICE) guidelines... read more →

Bedfont® Scientific Limited hosted an informative webinar Children with Asthma, with seasoned respiratory nurse Carol Stonham MBE leading the discussion along with Kirsty at Medway Asthma Self-Help (MASH). The webinar was a private screening for local Medway football coaches and gave valuable insights on managing, treating and recognising an asthma... read more →

World Lung Day was created in 2017 by the Forum of International Respiratory Societies (FIRS), the day was established to raise awareness about lung health and advocate for better lung health globally. Celebrated annually on the 25th of September, FIRS brings together several major respiratory organisations, including the American Thoracic... read more →

Methods of measuring FeNO Fractional exhaled Nitric Oxide (FeNO) measurement plays a crucial role in the diagnosis and management of airway inflammation. FeNO testing is recommended in the joint guidelines from the National Institute for Health and Care Excellence (NICE), the British Thoracic Society (BTS), and the Scottish Intercollegiate Guidelines Network (SIGN) for the diagnosis and management of asthma1.  In 2005... read more →

FeNO Testing in As Although airway eosinophilic inflathma Caremmation is a key characteristic of asthma, there are few methods available to measure it. This inflammation can be assessed by measuring eosinophils and eosinophilic cationic protein (ECP) in sputum or by measuring ECP in blood samples1. However, these methods are considered... read more →